# A Phase 1 Study to Evaluate the Safety and Pharmacokinetics of ABBV-243 in Healthy Adults.

> **NCT07306754** · PHASE1 · RECRUITING · sponsor: **AbbVie** · enrollment: 66 (estimated)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** ABBV-243
- **DRUG:** Placebo
- **DRUG:** ABBV-243
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07306754
- **Lead sponsor:** AbbVie
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-17
- **Primary completion:** 2027-05
- **Final completion:** 2027-05
- **Target enrollment:** 66 (ESTIMATED)
- **Last updated:** 2026-01-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07306754

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07306754, "A Phase 1 Study to Evaluate the Safety and Pharmacokinetics of ABBV-243 in Healthy Adults.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07306754. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*